Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients

NCT07568041 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease (AD)

Interventions

DRUG: 8M2D
DRUG: Placebo

Sponsor

Cenna Biosciences Inc.